Annex Advisory Services’s Novartis NVS Stock Holding History

Annex Advisory Services’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,991	Closed	-$201K	–	298
2023 Q4	$201K	Sell	1,991 -33	-2%	-$3.19K	0.01%	256
2023 Q3	$206K	Sell	2,024 -567	-22%	-$57.6K	0.01%	242
2023 Q2	$261K	Sell	2,591 -196	-7%	-$19.6K	0.01%	216
2023 Q1	$256K	Sell	2,787 -298	-10%	-$26K	0.01%	197
2022 Q4	$280K	Sell	3,085 -941	-23%	-$79.3K	0.02%	196
2022 Q3	$306K	Sell	4,026 -931	-19%	-$77.2K	0.02%	175
2022 Q2	$419K	Sell	4,957 -6,800	-58%	-$597K	0.03%	157
2022 Q1	$1.03M	Sell	11,757 -2,081	-15%	-$180K	0.08%	124
2021 Q4	$1.21M	Sell	13,838 -2,755	-17%	-$229K	0.08%	116
2021 Q3	$1.36M	Sell	16,593 -296	-2%	-$26.6K	0.11%	96
2021 Q2	$1.53M	Sell	16,889 -172	-1%	-$15.3K	0.12%	95
2021 Q1	$1.46M	Sell	17,061 -3,319	-16%	-$298K	0.14%	90
2020 Q4	$1.92M	Buy	+20,380	New	+$1.78M	0.19%	78

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Annex Advisory Services's NVS Position: Q1 2024 in Review

Annex Advisory Services sold out of Novartis (NVS) in Q1 2024, closing a stake of 1,991 shares — an estimated $201K sold.

Annex Advisory Services first reported a position in NVS in Q4 2020 and held it in 13 quarters. The position peaked at $1.92M in Q4 2020. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

Annex Advisory Services reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
Annex Advisory Services sold 1,991 Novartis shares in Q1 2024, an estimated $201K.
Annex Advisory Services first reported a position in Novartis in Q4 2020 and held it in 13 quarters.
Annex Advisory Services's Novartis position peaked at $1.92M in Q4 2020.
1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Annex Advisory Services's 13F filing for Q1 2024, filed 12 Apr 2024.